Research
An AI-Based Drug Discovery Tool Goes Beyond Protein Structures
The Scientist · By Sneha Khedkar ·
The Brief
- A structure-agnostic AI model predicts protein-drug interactions across the human proteome, according to The Scientist.
- The model does not depend on known protein 3D structures to make its predictions.
- The source reports the approach as opening new avenues for drug discovery.
Why it matters
Predicting drug-protein interactions without requiring solved protein structures could widen the set of targets that drug discovery researchers can screen computationally.
Who’s affected
- drug discovery researchers
- computational biologists
- #drug discovery
- #protein interactions
- #artificial intelligence
- #proteomics
- #computational biology
A structure-agnostic AI model predicts protein-drug interactions across the human proteome, opening new avenues for drug discovery.
Timeline
The Scientist published an article on the AI model for protein-drug interaction prediction
The Scientist Atom Feed
An AI-Based Drug Discovery Tool Goes Beyond Protein Structures